| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.4 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.4 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.4 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.4 |
| mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |